Jonathan Dixon
Consejero General en BIONANO GENOMICS, INC. .
Fortuna: 2 675 $ al 30/04/2024
Perfil
Jonathan Dixon is currently the Global Head-Legal at Bionano Genomics, Inc. He previously worked as the Legal Director at GeneOhm Sciences, Inc., Associate General Counsel at Becton, Dickinson & Co., and Associate General Counsel at CareFusion Corp.
Dixon received his undergraduate degree from Brigham Young University and his graduate degree from Lewis & Clark Law School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIONANO GENOMICS, INC.
0.01% | 15/02/2024 | 3 525 ( 0.01% ) | 2 675 $ | 30/04/2024 |
Cargos activos de Jonathan Dixon
| Empresas | Cargo | Inicio |
|---|---|---|
| BIONANO GENOMICS, INC. | Consejero General | 01/01/2023 |
Antiguos cargos conocidos de Jonathan Dixon.
| Empresas | Cargo | Fin |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
| CAREFUSION CORPORATION | Corporate Officer/Principal | - |
GeneOhm Sciences, Inc.
 GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Director/Miembro de la Junta | - |
Formación de Jonathan Dixon.
| Brigham Young University | Undergraduate Degree |
| Lewis & Clark Law School | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BIONANO GENOMICS, INC. | Health Technology |
| BECTON, DICKINSON AND COMPANY | Health Technology |
| Empresas privadas | 2 |
|---|---|
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Health Technology |
CareFusion Corp.
 CareFusion Corp. Medical DistributorsDistribution Services CareFusion Corp. engages in the manufactures of medical equipment and device. The company was founded on February 4, 2009 and is headquartered in San Diego, CA. | Distribution Services |
- Bolsa de valores
- Insiders
- Jonathan Dixon
